LEGAL ASPECTS OF DIRECT-TO-CONSUMER GENETIC TESTS.
Journal Title: Journal of IMAB - Annual Proceeding (Scientific Papers) - Year 2011, Vol 17, Issue 1
Abstract
Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on a genetic disorder. The main difference between direct-to-consumer genetic testing and the standard genetic testing is the way informational support is provided in internet offers of testing. Counselling may be offered as an additional special service at extra costs and at the customer's request. It may also be that a recommendation or at least an offer is given for the customer to contact a doctor or health practitioner from the company via phone for counselling. In a liberal society the fundamental individual rights can be considered to include access to medical treatment and diagnostics that may be helpful for improving one's health condition or that can help an individual make decisions regarding life style and health. At the European level, there are no binding legal regulations that specifically apply for genetic testing. In some European counties, national laws, require a responsible medical person to be involved before a genetic test is provided. The Convention on Human Rights and Biomedicine was adopted by the Committee of Ministers on 19 November 1996, while an Additional Protocol to the Convention, concerning Genetic Testing for Health Purposes, was adopted by the Committee of Ministers on 7 May 2008. Direct-to-consumer genetic testing is closely watched by the community of medical genetics and counsellors, and the EU funded Eurogentest Network of Excellence. In 2010, the European Society of Human Genetics has releaseda statement on direct-to-consumer gene testing for health-related purposes. The European Society of Human Genetics is concerned about the way in which commercial companies are currently introducing genetic tests into the market outside of the scope of the traditional healthcare system.
Authors and Affiliations
Mariela Yaneva – Deliverska
Keywords
Related Articles
- EP ID EP131033
- DOI 10.5272/jimab.2011171.135
- Views 122
- Downloads 0
ORGANIZATIONAL STRUCTURE OF RESEARCH PROJECT ACTIVITIES PERFORMED AT MEDICAL UNIVERSITIES IN BULGARIA
Introduction: There are five Bulgarian medical universities in the cities of Sofia, Plovdiv, Varna, Pleven and Stara Zagora. A major priority of medical universities is to encourage research activities mainly aimed at pr...
LITHIUM TOXICITY IN ELDERLY-A CASE REPORT AND DISCUSSION
Background: The therapeutic effect of Lithium as a mono therapy or as an augmenting agent in a variety of medical and psychiatric disorders is under doubt. However, lithium is associated with a number of adverse ef...
APPLICATION OF PEDICLE FLAPS FOR WOUND COVERAGE OF LOWER LEG
This paper presents 11 clinical cases with soft tissue defect of lower leg and foot. The reconstructive surgery of the wounds involves 14 pedicle flaps: five of which are gastrocnemius; nine are sural flaps. The et...
SOME PHARMACOLOGIC TREATMENT OPTIONS IN LATER- LIFE ANXIETY DISORDERS
Most recommendations for treatment of anxiety in later life are based on evidence, derived from studies of younger populations. An important challenge is the high psychic and physical comorbidity of primary anxiety...
A CASE OF NEUROFIBROMATOSIS TYPE 1
Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. Neurofibromatosis type...